These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 26280815

  • 21. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics.
    Mytsyk Y, Nakonechnyi Y, Dosenko V, Kowal P, Pietrus M, Gazdikova K, Labudova M, Caprnda M, Prosecky R, Dragasek J, Kruzliak P, Dats R.
    Clin Biochem; 2023 Jun; 116():120-127. PubMed ID: 37121562
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [Abstract] [Full Text] [Related]

  • 26. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.
    Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ.
    Eur Urol; 2015 Apr; 67(4):619-26. PubMed ID: 25457014
    [Abstract] [Full Text] [Related]

  • 27. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
    Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA.
    Eur Urol; 2008 Nov; 54(5):1081-8. PubMed ID: 18602209
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer.
    Rice KR, Chen Y, Ali A, Whitman EJ, Blase A, Ibrahim M, Elsamanoudi S, Brassell S, Furusato B, Stingle N, Sesterhenn IA, Petrovics G, Miick S, Rittenhouse H, Groskopf J, McLeod DG, Srivastava S.
    Clin Cancer Res; 2010 Mar 01; 16(5):1572-6. PubMed ID: 20160063
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X, Foj L.
    Int J Mol Sci; 2016 Oct 26; 17(11):. PubMed ID: 27792187
    [Abstract] [Full Text] [Related]

  • 32. TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.
    Dong J, Xiao L, Sheng L, Xu J, Sun ZQ.
    Asian Pac J Cancer Prev; 2014 Oct 26; 15(7):3099-103. PubMed ID: 24815454
    [Abstract] [Full Text] [Related]

  • 33. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
    Tsourlakis MC, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, Graefen M, Huland H, Salomon G, Steuber T, Wilczak W, Sirma H, Simon R, Sauter G, Minner S, Quaas A.
    Am J Pathol; 2014 Mar 26; 184(3):609-17. PubMed ID: 24378408
    [Abstract] [Full Text] [Related]

  • 34. Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
    Mosquera JM, Perner S, Demichelis F, Kim R, Hofer MD, Mertz KD, Paris PL, Simko J, Collins C, Bismar TA, Chinnaiyan AM, Rubin MA.
    J Pathol; 2007 May 26; 212(1):91-101. PubMed ID: 17385188
    [Abstract] [Full Text] [Related]

  • 35. Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.
    De Luca S, Passera R, Cappia S, Bollito E, Randone DF, Milillo A, Papotti M, Porpiglia F.
    BJU Int; 2014 Dec 26; 114(6b):E56-E61. PubMed ID: 24472071
    [Abstract] [Full Text] [Related]

  • 36. Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy.
    Ochiai A, Okihara K, Kamoi K, Iwata T, Kawauchi A, Miki T, Fors Z.
    Int J Urol; 2011 Mar 26; 18(3):200-5. PubMed ID: 21332814
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer].
    Guo XQ, Gui YT, Cai ZM.
    Yi Chuan; 2011 Feb 26; 33(2):117-22. PubMed ID: 21377967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.